登录     注册     关注 (0)
0 项商品 ¥0
BCS04017b Lung adenocarcinoma tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BCS04017a
Product Image
Cores 96 Cases 48
Row number 8 Column number 12
Core Diameter(mm) 1.5 Thickness(µm) 5.0
Tissue Array Type FFPE Species Human
QA/QC 经H&E染色和免疫组化(IHC)染色验证
Applications 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。
Notes 1. 收到产品后请在4°保存,并在3个月内使用;
2. 请在实验前60°烤片30分钟;
3.请选择温和的修复方式,以免造成组织脱落。

BCS04017b

Lung adenocarcinoma tissue microarray, containing 44 cases adenocarcinoma, 4 mucinous adenocarcinoma, duplicate cores per case

分类: 终止供货阵列  

亚分类: Duplicate cores per case   Stage (TNM)  

  • ¥2,030
  • ¥2,030
  • 4 days left
Alenabio
BCS04017b(serial)
1
2
3
4
5
6
7
8
9
10
11
12
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Adr
BCS04017b  (-)
Age:-
Sex:
Organ(Anatomic Site):
Pathology diagnosis:
TNM:
Grade:
Stage:
Type:

Legend: Lun-Lung

  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
Pos. No. Age Sex Organ Pathology diagnosis TNM Grade stage Type
A1 1 55 F Lung Adenocarcinoma T2N0M0 1 IB Malignant
A2 2 55 F Lung Adenocarcinoma T2N0M0 1 IB Malignant
A3 3 62 F Lung Adenocarcinoma T2N1M0 1 IIB Malignant
A4 4 62 F Lung Adenocarcinoma with necrosis T2N1M0 1 IIB Malignant
A5 5 41 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A6 6 41 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A7 7 69 M Lung Mucinous adenocarcinoma T2N1M0 1 IIB Malignant
A8 8 69 M Lung Mucinous adenocarcinoma T2N1M0 1 IIB Malignant
A9 9 43 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A10 10 43 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A11 11 52 M Lung Adenocarcinoma T2N0M0 * IB Malignant
A12 12 52 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
B1 13 52 M Lung Adenocarcinoma T3N1M0 1 IIIA Malignant
B2 14 52 M Lung Adenocarcinoma T3N1M0 1 IIIA Malignant
B3 15 56 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
B4 16 56 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
B5 17 43 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B6 18 43 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B7 19 52 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B8 20 52 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B9 21 69 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
B10 22 69 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
B11 23 59 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
B12 24 59 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
C1 25 67 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C2 26 67 F Lung Adenocarcinoma with necrosis T2N1M0 2 IIB Malignant
C3 27 52 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
C4 28 52 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
C5 29 58 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C6 30 58 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C7 31 46 F Lung Adenocarcinoma T1N0M0 2 IA Malignant
C8 32 46 F Lung Adenocarcinoma T1N0M0 2 IA Malignant
C9 33 62 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
C10 34 62 M Lung Adenocarcinoma T2N0M0 * IB Malignant
C11 35 50 M Lung Adenocarcinoma T3N1M0 2 IIIA Malignant
C12 36 50 M Lung Adenocarcinoma T3N1M0 2 IIIA Malignant
D1 37 65 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
D2 38 65 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
D3 39 64 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D4 40 64 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D5 41 55 M Lung Adenocarcinoma (sparse) T2N0M0 2 IB Malignant
D6 42 55 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D7 43 50 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D8 44 50 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D9 45 68 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
D10 46 68 M Lung Mucinous adenocarcinoma T2N0M0 * IB Malignant
D11 47 43 F Lung Mucinous adenocarcinoma T1N0M0 2 IA Malignant
D12 48 43 F Lung Mucinous adenocarcinoma T1N0M0 2 IA Malignant
E1 49 57 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
E2 50 57 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
E3 51 71 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
E4 52 71 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
E5 53 45 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E6 54 45 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E7 55 59 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E8 56 59 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E9 57 65 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
E10 58 65 M Lung Adenocarcinoma (sparse) T2N1M0 * IIB Malignant
E11 59 70 M Lung Adenocarcinoma T4N2M0 3 IIIB Malignant
E12 60 70 M Lung Adenocarcinoma T4N2M0 3 IIIB Malignant
F1 61 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
F2 62 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
F3 63 57 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
F4 64 57 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
F5 65 70 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
F6 66 70 M Lung Adenocarcinoma (sparse) T2N1M0 * IIB Malignant
F7 67 62 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F8 68 62 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F9 69 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F10 70 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F11 71 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F12 72 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G1 73 61 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
G2 74 61 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
G3 75 51 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G4 76 51 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G5 77 45 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
G6 78 45 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
G7 79 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G8 80 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G9 81 58 M Lung Adenocarcinoma T2N2M0 * IIIA Malignant
G10 82 58 M Lung Adenocarcinoma T2N2M0 * IIIA Malignant
G11 83 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
G12 84 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
H1 85 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H2 86 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H3 87 61 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H4 88 61 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H5 89 40 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H6 90 40 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H7 91 60 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H8 92 60 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H9 93 53 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H10 94 53 M Lung Adenocarcinoma with necrosis T2N0M0 3 IB Malignant
H11 95 58 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H12 96 58 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
- 42 M Adrenal gland Pheochromocytoma (tissue marker) - - - Malignant
Notes:“*” means invalid core; “-” means no classification or negative in IHC markers.